Your browser doesn't support javascript.
loading
[How can we nowadays select the best embryo to transfer?]. / Comment sélectionner aujourd'hui le meilleur embryon à transférer ?
Alter, L; Boitrelle, F; Sifer, C.
Afiliación
  • Alter L; Service d'histologie embryologie, biologie de la reproduction, cytogénétique et génétique médicale, CHI Poissy/Saint-Germain-en-Laye, 10, rue du Champ-Gaillard, 78303 Poissy cedex, France. Electronic address: alter.laura@hotmail.fr.
  • Boitrelle F; Service d'histologie embryologie, biologie de la reproduction, cytogénétique et génétique médicale, CHI Poissy/Saint-Germain-en-Laye, 10, rue du Champ-Gaillard, 78303 Poissy cedex, France.
  • Sifer C; Service de biologie de la reproduction, CHU Jean-Verdier, AP-HP, avenue du 14-Juillet, 93143 Bondy, France.
Gynecol Obstet Fertil ; 42(7-8): 515-25, 2014.
Article en Fr | MEDLINE | ID: mdl-24951187
Multiple pregnancies stand as the most common adverse outcome of assisted reproduction technologies (ART) and the dangers associated with those pregnancies have been reduced by doing elective single embryo transfers (e-SET). Many studies have shown that e-SET is compatible with a continuously high pregnancy rate per embryo transfer. Yet, it still becomes necessary to improve the selection process in order to define the quality of individual embryos - so that the ones we choose for transfer are more likely to implant. First, analysis of embryo morphology has greatly helped in this identification and remains the most relevant criterion for choosing the embryo. The introduction of time-lapse imaging provides new criteria predictive of implantation potential, but the real contribution of this system - including the benefit/cost ratio - seems to be not yet properly established. In this context, extended culture until blastocyst stage is an essential practice but it appears wise to keep it for a population showing a good prognosis. Then, the failure of aneuploid embryos to implant properly led to achieve preimplantation genetic screening (PGS) in order to increase pregnancy and delivery rates after ART. However, PGS by fluorescence in situ hybridization (FISH) at day 3 is a useless process - and may even be harmful. Another solution involves using comparative genomic hybridisation (CGH) and moving to blastocyst biopsy. Finally, it is envisaged that morphology will also be significantly aided by non-invasive analysis of biomarkers in the culture media that give a better reflection of whole-embryo physiology and function.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transferencia de Embrión Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Pregnancy Idioma: Fr Revista: Gynecol Obstet Fertil Asunto de la revista: GINECOLOGIA / OBSTETRICIA Año: 2014 Tipo del documento: Article Pais de publicación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transferencia de Embrión Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Pregnancy Idioma: Fr Revista: Gynecol Obstet Fertil Asunto de la revista: GINECOLOGIA / OBSTETRICIA Año: 2014 Tipo del documento: Article Pais de publicación: Francia